A scientific team supported in part by the National Institutes of Health (NIH) has developed a new, ultra-high-resolution ...

Artificial intelligence (AI) models trained on large datasets are increasingly seen as the key to unlocking personalized ...

In relapsing-remitting multiple sclerosis, activation of the peripheral immune system can lead to focal inflammation within the CNS. Over the past three decades, therapeutic development has been ...

Antonella Favit-Van Pelt, MD, PhD, discusses the use of neuromodulation and neuroplasticity for addressing gait deficits in patients with multiple sclerosis.

A significant number of people lose their lives to multiple sclerosis each year, and many of these victims come from rural areas. However, the technology for early sclerosis diagnosis is not as ...

A new technology that uses clinical MRI machines to image metabolic activity in the brain could give researchers and clinicians unique insight into brain function and disease, researchers at the ...

Multiple sclerosis (MS) is a major, immune-mediated, demyelinating disease and the major cause of non-traumatic disability in young adults. Susceptibility to disease is controlled by a variety of ...

Multiple sclerosis (MS) is a demyelinating disease that affects the central nervous system (CNS) and is characterized by the presence of CNS lesions. Volumetric measures of tissues, including lesions, ...

Occasionally, MRI would demonstrate microhemorrhages, which were felt to be diffuse axonal injury, but of unclear clinical significance.

In people with benign MS, there is a loss of overall brain tissue but other parts of the brain may grow to help compensate for the damage, a study suggests.

In 2024, the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) congress celebrated a remarkable 40 years of pioneering work. Regional committees have emerged around the ...